Daltonganj: A surprise inspection by the civil surgeon at Pindrahi Health Sub-Centre under Chhaterpur Sub-Divisional Hospital ...

When Mateo Ramirez's doctor gave him the antibiotic ciprofloxacin to treat his stomach bug, he had no idea he would become ...

BSAC: British Society of Antimicrobial Chemotherapy guidelines; CLSI: Clinical and Laboratory Standard Institute; DIN: German Deutsches Institut für Normung; EUCAST: European Committee on ...

The drug targets multi-drug-resistant pathogens, a growing concern in global healthcare, and could provide a much-needed alternative to older antibiotics like azithromycin. Both Zaynich and Miqnaf are ...

That’s because the scientists are Brown undergraduates enrolled in an immersive course called Antibiotic Drug Discovery: Identifying Novel Soil Microbes to Combat Antibiotic Resistance. The class runs ...

"The $7.3 billion is the difference between what they are reimbursing themselves and what it is estimated to cost them to acquire the drug," an FTC spokesperson told reporters in a press briefing ...

A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing drug ...

Antibiotic treatment for drug-resistant tuberculosis found to be safe and effective in clinical trial. ScienceDaily . Retrieved February 4, 2025 from www.sciencedaily.com / releases / 2025 / 01 ...

The review was prompted by an application from Cipla Limited, challenging the earlier price fixation of its product Azee 250 mg tablet 6's, the antibiotic used to treat a variety of bacterial ...

Wockhardt's shares rose 4% on Monday, January 13, after the company said its drug Zaynich (WCK 5222) showed over 97% effectiveness in treating serious infections caused by carbapenem-resistant ...

Harry Sumnall receives funding from public grant awarding bodies for alcohol and other drugs research, and fees from (international) not-for-profit organisations and government departments for ...

In June last year, Wockhardt revealed its plans to launch its novel antibiotic drug, Zaynich (WCK 5222), in India by the end of 2024-25, followed by a global launch in 2025-26. According to media ...